63 filings
Page 3 of 4
6-K
ndb0xstlneoz6u ynogc
17 May 22
PainReform Provides Business Update for the First Quarter of 2022
7:52am
6-K
mhhfrxi
16 May 22
Condensed Financial Statements
4:31pm
6-K
cqocu5
17 Mar 22
PainReform Provides Year-End Business Update; On track to Commence Phase 3 Trial of
8:31am
6-K
nrlekdu
9 Dec 21
Current report (foreign)
4:30pm
6-K
bsix qtjenfnxo12bs
16 Nov 21
PainReform Provides Business Update for the Third Quarter of 2021
8:24am
6-K
5y25o
15 Nov 21
Condensed Financial Statements
4:15pm
6-K
z4zjh7oaue3d
27 Oct 21
Annual General Meeting of Shareholders to Be
4:40pm
6-K
iq3hqm3k0 21s3g
25 Oct 21
Current report (foreign)
4:30pm
6-K
irjhlp
16 Aug 21
Current report (foreign)
8:17am
6-K
ybpc t0jm59nv3kc
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
6-K
agrot3xovpp6v 2wce
18 Mar 21
PainReform Provides Year-End Business Update and Reports Progress Towards
10:36am
6-K
n6ixf3o
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
6qmmswqyeve528vh5t
1 Mar 21
Report of Foreign Private Issuer
7:00am
6-K
h0se ujgapo4
23 Feb 21
Report of Foreign Private Issuer
4:30pm
6-K
baod9mv4n
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
w7l k916ap
6 Jan 21
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
9:00am
6-K
p1hsx2 sj
5 Jan 21
Investor Presentation January 2021
4:15pm
6-K
vm7ilx4ou80s vqvqia
4 Jan 21
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
4:16pm
6-K
mrs0yco4ilxmowt
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am
6-K
8i0oodw
13 Nov 20
Report of Foreign Private Issuer
6:09am